Used in research as a selective inhibitor of Src homology 2 domain-containing phosphatase-2 (SHP2), playing a role in studying signaling pathways involved in cancer and other diseases. Shows potential in blocking oncogenic signaling, particularly in RAS-driven tumors. Also applied in immunological studies to modulate T cell activation and improve anti-tumor immune responses. Investigated for use in combination therapies with other targeted agents or immunotherapies to enhance efficacy.